novartis ag-sponsored adr
Transactions by NOVARTIS AG-SPONSORED ADR (NOTA) in the last 6 months
Raze Therapeutics announced that it has received $24 million in its series A round of funding on October 14, 2014. The transaction included participation from new investors, Atlas Venture L.P., MPM Capital, Merck Serono S.A., Investment Arm, Partners Innovation Fund, Astellas Venture Management LLC, and Novartis AG. As part of the round, Ansbert Gadicke of MPM Capital, Nilesh Kumar of Merck Serono S.A., Investment Arm, Reza Halse of Partners Innovation Fund, Jason Rhodes ...
Atlas Venture L.P.
Merck Serono S.A., Investment Arm
Partners Innovation Fund
Gamida Cell Ltd. announced that it will receive $35 million in a round of funding from Novartis AG on August 18, 2014. The investor will acquire 15% stake in the company through this transaction. The investor also has an option to fully acquire the company. The option is exercisable for a limited period of time following achievement of certain milestones connected to the development of NiCord, which is anticipated to be met during 2015. The option, if not exercised, ...
Seventh Sense Biosystems, Inc. announced that it will receive $16,467,084 in funding on July 28, 2014. The company will issue common shares, convertible debt and an option, warrant or other right to acquire another security in the transaction. The company will issue securities pursuant to exemption provided under Regulation D. As of August 8, 2014, the company has received $10,467,084 in its first tranche close from eight investors.
Laboratory Corp. of America Holdings
Siemens Financial Services, Inc.
dievini Hopp BioTech holding GmbH & Co. KG entered into an agreement to acquire additional 67% stake in LTS Lohmann Therapie-Systeme AG from BWK GmbH Unternehmensbeteiligungsgesellschaft and Novartis AG (SWX:NOVN) on July 16, 2014. The transaction is subject to regulatory approvals, other customary conditions and is expected to close in 2014. As of September 8, 2014, Federal Trade Commission approved the transaction. Morgan Stanley Bank AG acted as financial advisor ...
|Johnson & Johnson||$102.48 USD||+1.26|
|Merck & Co Inc||$56.78 USD||+1.26|
|Pfizer Inc||$28.76 USD||+0.459|
|Roche Holding AG||SFr.279.40 CHF||+1.10|
|Procter & Gamble Co/The||$83.08 USD||-1.15|
|View Industry Companies|